Patent details

EP2885266 Title: PROCESS FOR THE PREPARATION OF (2Z,5Z)-5-(3-CHLORO-4-((R)-2,3-DIHYDROXYPROPOXY)BENZYLIDENE)-2-(PROPYLIMINO)-3-(O-TOLYL)THIAZOLIDIN-4-ONE AND INTERMEDIATE USED IN SAID PROCESS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2885266
WO Application Number:
IB2013056662
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP13779378.2
WO Publication Number:
WO2014027330
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
15/08/2013
Grant date:
18/03/2020
EP Publication Date:
24/06/2015
WO Publication Date:
20/02/2014
Claims Translations Received Date:
Claims Translation B1 Received Date:
28/05/2020
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
18/03/2020
EP B1 Publication Date:
18/03/2020
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
14/08/2033
Lapsed By Expiration Date:
Patent Validated Date:
09/06/2020
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
14/08/2025
 
 

 

Name:
Laboratoires Juvise Pharmaceuticals
Address:
149, Boulevard Bataille de Stalingrad, 69100, Villeurbanne, France (FR)

Historical Applicant/holder

From:
18/03/2020
To:
14/08/2025

 

Name:
Actelion Pharmaceuticals Ltd
Address:
Gewerbestrasse 16, 4123 Allschwil, Switzerland (CH)

Agent

Name:
ir. W.J.J.M. Kempes
From:
08/06/2020
Address:
Dogio Patents Postbus 2350, 1200 CJ, Hilversum, Netherlands (NL)
To:

Inventor

Name:
HERSE, Christelle
Address:
CH-3930 Visp, Switzerland (CH)

Priority

Priority Patent Number:
12180920
Priority Date:
17/08/2012
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
C07C 45/64; C07C 45/81; C07C 47/575; C07D 277/54;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
34/25
Publication date:
20/08/2025
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
24/20
Publication date:
10/06/2020
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
12/20
Publication date:
18/03/2020
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202012
Publication date:
18/03/2020
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202501337A
Date Registered:
14/08/2025
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Dennemeyer & Associates S.A.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Laboratoires Juvise Pharmaceuticals
Address:
149, Boulevard Bataille de Stalingrad, 69100, Villeurbanne, France (FR)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/08/2026
Annual Fee Number:
14
Annual Fee Amount:
800 Euro
Last Annual Payment Date:
21/08/2025
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
700 Euro
Payer:
Dennemeyer and Co
Filing date Document type Document Description Number of pages File Type
08/06/2020 Outgoing Correspondence Letter no formal defects 1 PDF /8/1/9/8/2/0800528918/docs/ep13779378.2_1_347999l271.pdf
28/05/2020 Claims First filed claims 3 PDF /8/1/9/8/2/0800528918/docs/ep13779378.2_0_claims20200528134520909.pdf